SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

63.66

163771.55

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.49

Back

Nephro Care India Ltd - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Oct 04,2025

Nephro Care India Limited has informed regarding Submission of Non applicability of the Compliance Report on Corporate Governance for the Quarter ended 30th September 2025

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)